Mercury Biopharmaceutical Corporation (TPEX:6932)

Taiwan · Delayed Price · Currency is TWD

13.05

+0.15 (1.16%)

May 14, 2025, 1:27 PM CST

Revenue by Product

Fiscal year is January - December.

Year Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Pharmaceutical	1.03M	Log In
Pharmaceutical Growth	-61.46%	Log In

Revenue by Geography

Fiscal year is January - December.

Year Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Singapore	1.03M	Log In
Taiwan	-	Log In
United States	-	Log In